Follow
C. Sophia Albott MD
C. Sophia Albott MD
Assistant Professor of Psychiatry, University of Minnesota
Verified email at umn.edu
Title
Cited by
Cited by
Year
Battle buddies: rapid deployment of a psychological resilience intervention for health care workers during the COVID-19 pandemic
CS Albott, JR Wozniak, BP McGlinch, MH Wall, BS Gold, S Vinogradov
Anesthesia & Analgesia 131 (1), 43-54, 2020
5292020
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
PR Shiroma, B Johns, M Kuskowski, J Wels, P Thuras, CS Albott, KO Lim
Journal of affective disorders 155, 123-129, 2014
2202014
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
PR Shiroma, CS Albott, B Johns, P Thuras, J Wels, KO Lim
International Journal of Neuropsychopharmacology 17 (11), 1805-1813, 2014
1312014
Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression
CS Albott, KO Lim, MK Forbes, C Erbes, SJ Tye, JG Grabowski, P Thuras, ...
The Journal of clinical psychiatry 79 (3), 17462, 2018
1202018
Association of childhood adversity with differential susceptibility of transdiagnostic psychopathology to environmental stress in adulthood
CS Albott, MK Forbes, JJ Anker
JAMA network open 1 (7), e185354-e185354, 2018
822018
Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study
KR Cullen, P Amatya, MG Roback, CS Albott, M Westlund Schreiner, ...
Journal of child and adolescent psychopharmacology 28 (7), 437-444, 2018
772018
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
PR Shiroma, P Thuras, J Wels, CS Albott, C Erbes, S Tye, KO Lim
Translational psychiatry 10 (1), 206, 2020
712020
The antidepressant effect of repeat dose intravenous ketamine is delayed by concurrent benzodiazepine use
CS Albott, PR Shiroma, KR Cullen, B Johns, P Thuras, J Wels, KO Lim
The Journal of clinical psychiatry 78 (3), 1863, 2017
382017
Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression
PR Shiroma, P Thuras, J Wels, CS Albott, C Erbes, S Tye, KO Lim
Journal of Affective Disorders 277, 470-477, 2020
342020
Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: preliminary evidence in adolescents with treatment-resistant depression
AV Roy, M Thai, B Klimes-Dougan, M Westlund Schreiner, BA Mueller, ...
Journal of Psychopharmacology 35 (2), 168-177, 2021
202021
Batres-Y-Carr, TM, Wels, J., & Shiroma, PR (2018). Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment …
CS Albott, KO Lim, MK Forbes, C Erbes, SJ Tye, JG Grabowski, P Thuras
J. Clin. Psychiatry 79, 0
12
Neural and behavioral correlates of clinical improvement to ketamine in adolescents with treatment resistant depression
M Thai, Z Başgöze, B Klimes-Dougan, BA Mueller, M Fiecas, KO Lim, ...
Frontiers in Psychiatry 11, 820, 2020
102020
The effect of repeated ketamine infusion over facial emotion recognition in treatment-resistant depression: a preliminary report
PR Shiroma, CS Albott, B Johns, P Thuras, J Wels, KO Lim
The Journal of Neuropsychiatry and Clinical Neurosciences 27 (4), 362-364, 2015
92015
Advances and challenges in transcranial magnetic stimulation (TMS) research on motor systems
M Chen, CC Cline, KL Frost, TJ Kimberley, ST Nemanich, BT Gillick, ...
Engineering in Medicine, 283-318, 2019
72019
Neurocognitive effects of repeated ketamine infusions in comorbid posttraumatic stress disorder and major depressive disorder
CS Albott, KO Lim, C Erbes, P Thuras, J Wels, SJ Tye, PR Shiroma
Journal of Affective Disorders 308, 289-297, 2022
52022
Characterization of comorbid posttraumatic stress disorder and major depressive disorder using ketamine as an experimental medicine probe
CS Albott, S Lee, KR Cullen, P Thuras, S Lissek, J Wels, KJ Friedrich, ...
Journal of psychiatry and brain science 6, 2021
32021
Parkinson Disease: Current and Emerging Treatment Strategies.
A Ramirez-Zamora
The Journal of Clinical Psychiatry 79 (3), PP17030TX1C-PP17030TX1C, 2018
32018
3525 improvement in suicidal ideation after repeated ketamine infusions: Relationship to reductions in symptoms of posttraumatic stress disorder, depression, and pain
CS Albott, KO Lim, MK Forbes, P Thuras, J Wels, S Tye, P Shiroma
Journal of Clinical and Translational Science 3 (s1), 46-46, 2019
22019
267. outcomes from University of Minnesota clinical RTMS clinic for treatment-resistant depression: RTMS effects on suicidal Ideation as a function of baseline Anhedonia
AI Sonmez, AM Kruger, C Godoy-Henderson, C Sullivan, S Schmid, ...
Biological Psychiatry 93 (9), S201, 2023
12023
1001. Neurocognitive Effects of Repeated Ketamine Infusions in Co-Occurring Posttraumatic Stress Disorder and Treatment-Resistant Depression
C Albott, K Lim, M Forbes, C Erbes, P Thuras, S Tye, J Wels, P Shiroma
Biological Psychiatry 81 (10), S405, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20